Moreover, the association between NAFLD and adiponectin and the subsequent risk for LGA was evident already in the first trimester, suggesting increased risk of LGA at early stages of pregnancy. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.